These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36185199)

  • 1. Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma.
    Zou Z; Chai Y; Li Q; Lin X; He Q; Xiong Q
    Front Oncol; 2022; 12():958221. PubMed ID: 36185199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 3. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Dissection of Novel Lactate Metabolism-Related Signature in the Tumor Immune Microenvironment and Prognostic Prediction in Breast Cancer.
    Yang L; Tan P; Sun H; Zeng Z; Pan Y
    Front Oncol; 2022; 12():874731. PubMed ID: 35574387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma.
    Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A
    Front Oncol; 2022; 12():941156. PubMed ID: 36505813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer.
    Zhang Z; Fang T; Lv Y
    Front Genet; 2022; 13():934830. PubMed ID: 36171887
    [No Abstract]   [Full Text] [Related]  

  • 10. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
    Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
    Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
    [No Abstract]   [Full Text] [Related]  

  • 11. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
    Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
    Front Oncol; 2022; 12():904464. PubMed ID: 35912258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
    Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
    Front Immunol; 2022; 13():959967. PubMed ID: 36177002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data.
    Baldi S; He Y; Ivanov I; Sun Y; Feng W; Refat M; Mohammed SAD; Adlat S; Tian Z; Wang Y; Gao Y; Tian H
    Front Mol Biosci; 2022; 9():1102735. PubMed ID: 36582202
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.
    Liu L; Liang L; Mai G; Chen Y
    FASEB Bioadv; 2022 Sep; 4(9):585-601. PubMed ID: 36089979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
    Liu X; Fang X; Lu L; Liu G
    Front Genet; 2022; 13():996625. PubMed ID: 36568396
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
    Gao H; Xing F
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes.
    Ren Y; He S; Feng S; Yang W
    Front Public Health; 2022; 10():916364. PubMed ID: 35712285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
    Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y
    PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.